...
首页> 外文期刊>International Journal of Cardiology >Soroka acute myocardial infarction (SAMI) score predicting 10-year mortality following acute myocardial infarction
【24h】

Soroka acute myocardial infarction (SAMI) score predicting 10-year mortality following acute myocardial infarction

机译:Soroka急性心肌梗塞(SAMI)评分可预测急性心肌梗塞后10年死亡率

获取原文
获取原文并翻译 | 示例

摘要

As short-term survival from acute myocardial infarction (AMI) improves in the last 3 decades, better understanding of the long-term natural history and risk stratification tools becomes more important [1 ]. Long-term risk stratification is of great importance to both clinicians as benefits of costly interventions and medical treatments are greatest in patients at higher risk [2,3]. Thus, much effort has been put into designing and validating risk scores [2,4,5]. However, studies and scores evaluating long-term prognosis in unselected cohorts and including non-cardiologic co-morbidities are scarce. Recently we developed and validated a risk score, Soroka Acute Myocardial Infarction (SAMI) Score predicting one- and five-year mortality [6]. The SAMI score is a simple assessment tool, based entirely on "real life" available and easily accessible clinical information including a wide variety of non-cardiovascular co-morbidities [6].
机译:在最近的30年中,随着急性心肌梗死(AMI)的短期生存率的提高,对长期自然病史和风险分层工具的更好理解变得越来越重要[1]。长期风险分层对两位临床医生都很重要,因为高风险患者的昂贵干预措施和药物治疗获益最大[2,3]。因此,在设计和验证风险评分上已经付出了很多努力[2,4,5]。然而,缺乏针对未选人群的长期预后并包括非心脏病合并症的研究和评分。最近,我们开发并验证了风险评分Soroka急性心肌梗塞(SAMI)评分,该评分可预测一年和五年的死亡率[6]。 SAMI评分是一个简单的评估工具,完全基于可用的“现实生活”和易于获取的临床信息,包括多种非心血管合并症[6]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号